FDA Inspection 1075227 — Emcure Pharmaceuticals Limited
The FDA completed an inspection of Emcure Pharmaceuticals Limited on Oct 30, 2018 in Pune. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 30, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Pune (India)
Additional Details
Bioanalytical BA/BE